Immuneering Announces Participation in Piper Sandler AI/ML Investor Conference
CAMBRIDGE, Mass., April 01, 2022 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company using translational bioinformatics to advance...
Year: 2022
Reporting of transactions made by persons discharging managerial responsibilities and persons closely associated with them in NTG’s shares
Company announcement no. 4 - 221 April 2022 Reporting of transactions made by persons discharging managerial responsibilities and persons closely...
New Incentive Programs Established for Members of Executive and Other Management in Bavarian Nordic
COPENHAGEN, Denmark, April 1, 2022 – In accordance with the Company’s remuneration policy, the Board of Directors of Bavarian...
Philips showcases new innovations in the treatment of heart rhythm disorders at EHRA 2022
KODEX-EPD cardiac imaging and mapping system from Philips Philips KODEX-EPD cryoballoon procedure Philips GlideLight Laser Sheath for lead management Philips...
FDA requests supplementary information for Acarix breakthrough designation request for heart failure diagnosis
Press release (MAR)Malmö, Sweden, April 1, 2022 FDA requests supplementary information for Acarix breakthrough designation request for heart failure diagnosis The Food and...
Managers’ transactions
April 1, 2022Announcement no. 6 Managers’ transactions In connection with the completion of BioPorto A/S’ rights issue as described in...
Press Release: EUROAPI listing on Euronext Paris expected on May 6, 2022
EUROAPI listing on Euronext Paris expected on May 6, 2022 French AMF approved EUROAPI’s listing prospectus EUROAPI first day of...
Perimeter Medical Imaging AI Announces Its Participation in Multiple Upcoming Investor Conferences
TORONTO & DALLAS--(BUSINESS WIRE)--$PINK.V #AI--Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven...
CONMED Corporation to Announce First Quarter 2022 Financial Results on April 27, 2022
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter 2022 after...
6 Dosell are Implemented in a New Municipality
STOCKHOLM, SWEDEN / ACCESSWIRE / April 1, 2022 / iZafe Group (STO:IZAFE-B)iZafe Group (publ.) hereby announces that the partner Careium...
Love Hemp Group PLC Announces Response to the Latest FSA Novel Foods Update
LONDON, UK / ACCESSWIRE / April 1, 2022 / Love Hemp Group PLC (AQSE:LIFE)(OTCQB:WRHLF), the brand-led consumer goods company focussed...
Angle PLC Announces Identifying Drug Targets in Cancer Metastasis
PARSORTIX SYSTEM DEMONSTRATES ABILITY TO ISOLATE CTCs FOR DOWNSTREAM MOLECULAR ANALYSIS, IDENTIFYING KEY DRUG TARGETS INVOLVED IN CANCER METASTASISWorld-class research...
Relief Therapeutics Announces that its Subsidiary was Issued a Swiss Patent Entitled ‘Vasoactive Intestinal Peptide (VIP) for the Use in the Treatment of Drug-induced Pneumonitis’
GENEVA, SWITZERLAND / ACCESSWIRE / April 1, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (" Relief "), a biopharmaceutical company...
Spexis Publishes Invitation to Annual General Meeting 2022
Ad hoc announcement pursuant to Art. 53 LR- Pre-AGM information call on April 7, 2022 at 2:30PM CET- AGM to...
Relief Reports that its U.S. Collaboration Partner has Announced that the I-SPY COVID Trial Suggests No Clinical Benefit with Addition of Nebulized Aviptadil in Critically Ill Patients with COVID-19
GENEVA, SWITZERLAND / ACCESSWIRE / April 1, 2022 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY) (" Relief "), a biopharmaceutical company...
XPhyto Closes First Tranche of Financing
VANCOUVER, BC and UTTENWEILER, GERMANY / ACCESSWIRE / March 31, 2022 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company")...
Mycrodose Therapeutics Announces First Clinical Candidate for Ketamine-Based Drug Delivery Device for Oral Mucositis
San Diego, California--(Newsfile Corp. - March 31, 2022) - Mycrodose Therapeutics ("Mycrodose"), a leading US pharmaceutical company specializing in the...
Pulse Biosciences Reports Fourth Quarter & Full Year 2021 Financial Results
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™...
Global Launch of New Ultra-Portable Fundus Camera, from epipole, at Vision Expo East (NYC)
epiCam: the power of desktop retinal imaging, in the palm of your hand NEW YORK, March 31, 2022 /PRNewswire/ -- epipole,...
Orbita Welcomes New Heads of Sales and Marketing
Sarah Inman and Elizabeth Glaser join Orbita BOSTON, March 31, 2022 /PRNewswire/ -- Orbita, the leading provider of secure voice and...